BidaskClub lowered shares of Castlight Health, inc. (NYSE:CSLT) from a sell rating to a strong sell rating in a report published on Thursday.

CSLT has been the topic of a number of other research reports. Canaccord Genuity upgraded shares of Castlight Health, inc. from a hold rating to a buy rating in a report on Tuesday, October 10th. Cowen and Company reiterated a market perform rating and issued a $4.50 price target (up previously from $4.00) on shares of Castlight Health, inc. in a report on Thursday, August 3rd. Chardan Capital decreased their price target on shares of Castlight Health, inc. from $6.50 to $6.30 and set a buy rating on the stock in a report on Thursday, October 26th. ValuEngine lowered shares of Castlight Health, inc. from a hold rating to a sell rating in a report on Thursday, August 10th. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $5.00 price target on shares of Castlight Health, inc. in a report on Wednesday, October 25th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $5.22.

Shares of Castlight Health, inc. (NYSE CSLT) traded up $0.20 on Thursday, hitting $3.95. 254,700 shares of the company’s stock were exchanged, compared to its average volume of 323,867. Castlight Health, inc. has a 52 week low of $3.05 and a 52 week high of $5.50. The company has a current ratio of 1.94, a quick ratio of 1.94 and a debt-to-equity ratio of 0.03.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings results on Wednesday, October 25th. The software maker reported ($0.05) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.02. The company had revenue of $34.60 million for the quarter, compared to analyst estimates of $34.61 million. Castlight Health, inc. had a negative net margin of 45.14% and a negative return on equity of 32.57%. Castlight Health, inc.’s revenue for the quarter was up 35.7% on a year-over-year basis. During the same quarter last year, the business earned ($0.05) EPS. sell-side analysts forecast that Castlight Health, inc. will post -0.44 earnings per share for the current fiscal year.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/castlight-health-inc-cslt-downgraded-by-bidaskclub/1697994.html.

In related news, insider Giovanni M. Colella sold 23,800 shares of Castlight Health, inc. stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $4.05, for a total transaction of $96,390.00. Following the transaction, the insider now owns 78,906 shares in the company, valued at approximately $319,569.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Giovanni M. Colella sold 8,100 shares of Castlight Health, inc. stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $3.67, for a total transaction of $29,727.00. Following the transaction, the insider now owns 97,969 shares in the company, valued at approximately $359,546.23. The disclosure for this sale can be found here. Insiders have sold a total of 158,487 shares of company stock worth $597,608 in the last 90 days. Company insiders own 37.43% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. FMR LLC lifted its holdings in shares of Castlight Health, inc. by 49.2% during the 2nd quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock valued at $47,451,000 after acquiring an additional 3,768,009 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Castlight Health, inc. by 36.0% in the 2nd quarter. Vanguard Group Inc. now owns 3,636,948 shares of the software maker’s stock worth $15,094,000 after buying an additional 963,188 shares in the last quarter. Prudential PLC lifted its holdings in Castlight Health, inc. by 23.5% in the 2nd quarter. Prudential PLC now owns 2,002,706 shares of the software maker’s stock worth $8,311,000 after buying an additional 380,920 shares in the last quarter. Maverick Capital Ltd. lifted its holdings in Castlight Health, inc. by 2.8% in the 2nd quarter. Maverick Capital Ltd. now owns 1,221,809 shares of the software maker’s stock worth $5,071,000 after buying an additional 33,735 shares in the last quarter. Finally, General Electric Co. acquired a new position in Castlight Health, inc. in the 2nd quarter worth $4,338,000. Institutional investors and hedge funds own 41.30% of the company’s stock.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.